We would love to connect with you during the DIA and discuss how we can support you to optimise your path to market approval.
Working together we can:
- Accelerate your drug development program to reduce your time to approval
- Optimise the management of the regulatory process to provide accurate and predictable outcomes
- Reduce your risks and increase the probability of gaining Market Authorization
Don't miss our great speakers sharing their knowledge in different forums throughout the conference:
Dr Steffen Thirstrup - NDA Advisory Board Director
Neelu Agrawal - Pharmapprove
Carol Longson - ABPI
Tuesday, March 16th,15:00, Session #S0708: Value Communications and Negotiations – Are You Prepared?
Track 07: Value-Access
Dr Paula Salmikangas – NDA Advisory Board Director
Professor Beatriz Silva Lima - NDA Advisory Board member
Tuesday, March 16th,16:30, Session #S0303: De-risking regulatory strategy for ATMPs
Track 03: Regulatory Strategy
Dr Paula Salmikangas – NDA Advisory Board Director
Ilona Reischl (current CAT Vice-Chair) will be the chair of the session and Paula will be presenting together with Ursula Busse & Margit Jeschke (Novartis) and Karen Walker (Roche)
Track 05: CMC, Quality, GMP
Dr Brian Edwards - Principal Consultant
Track:02: Clinical Operations
Click here to download the full programme.
To pre-book a meeting with one our team simply
contact us meet-us@ndareg.com